Home/Filings/4/0001294002-05-000035
4//SEC Filing

IMMUNE RESPONSE CORP 4

Accession 0001294002-05-000035

CIK 0000817785operating

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 5:57 PM ET

Size

4.8 KB

Accession

0001294002-05-000035

Insider Transaction Report

Form 4
Period: 2005-09-30
THEOFAN GEORGIA
VP, Clinical Development
Transactions
  • Award

    Common Stock

    2005-09-30$0.46/sh+5,389$2,47929,629 total
Footnotes (1)
  • [F1]Matching company contribution to 401K account.

Issuer

IMMUNE RESPONSE CORP

CIK 0000817785

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000817785

Filing Metadata

Form type
4
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 5:57 PM ET
Size
4.8 KB